InspireMD Company Insiders
| NSPR Stock | USD 2.94 0.29 10.94% |
InspireMD employs about 65 people. The company is managed by 9 executives with a total tenure of roughly 23 years, averaging almost 2.0 years of service per executive, having 7.22 employees per reported executive. Discussion of InspireMD's management performance can provide insight into the enterprise performance.
| Sol Barer Chairman Independent Chairman of the Board |
InspireMD |
InspireMD's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with InspireMD's future performance. Based on our forecasts, it is anticipated that InspireMD will maintain a workforce of slightly above 70 employees by December 2024.InspireMD Management Team Effectiveness
The company has return on total asset (ROA) of (0.3724) % which means that it has lost $0.3724 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6675) %, meaning that it created substantial loss on money invested by shareholders. InspireMD's management efficiency ratios could be used to measure how well InspireMD manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/26/2024, Return On Tangible Assets is likely to drop to -0.44. In addition to that, Return On Capital Employed is likely to drop to -0.53. At this time, InspireMD's Total Assets are relatively stable compared to the past year. As of 11/26/2024, Total Current Assets is likely to grow to about 46.4 M, while Non Currrent Assets Other are likely to drop slightly above 654.2 K.As of 11/26/2024, Common Stock Shares Outstanding is likely to grow to about 25.5 M, while Net Loss is likely to drop (22.3 M).
InspireMD Workforce Comparison
InspireMD is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 1,836. InspireMD holds roughly 65.0 in number of employees claiming about 4% of equities under Health Care industry.
InspireMD Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific InspireMD insiders, such as employees or executives, is commonly permitted as long as it does not rely on InspireMD's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, InspireMD insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2024-06-01 | 1.0 | 2 | 2 | 118,125 | 118,125 |
| 2023-12-01 | 2.5 | 5 | 2 | 59,736 | 46,580 |
| 2020-12-01 | 1.0 | 2 | 2 | 444,446 | 79,650 |
| 2016-09-01 | 5.5 | 11 | 2 | 8,481,872 | 1,623 |
| 2016-03-01 | 0.4545 | 20 | 44 | 1,576,241 | 420,326 |
| 2015-12-01 | 0.5 | 2 | 4 | 127,650 | 51,438 |
| 2015-06-01 | 2.5 | 5 | 2 | 246,892 | 12,511 |
| 2015-03-01 | 11.0 | 33 | 3 | 8,561,910 | 67,879 |
| 2014-06-01 | 5.0 | 5 | 1 | 89,804 | 16,398 |
| 2014-03-01 | 16.0 | 16 | 1 | 1,324,210 | 29,286 |
| 2013-12-01 | 0.5 | 2 | 4 | 150,326 | 600,000 |
| 2013-09-01 | 2.0 | 2 | 1 | 975,000 | 850,000 |
| 2013-06-01 | 12.5 | 25 | 2 | 2,720,016 | 52,939 |
| 2013-03-01 | 1.6667 | 5 | 3 | 1,142,749 | 10,195 |
| 2012-12-01 | 3.5 | 7 | 2 | 1,165,235 | 821,754 |
| 2011-12-01 | 1.0 | 1 | 1 | 2,900,000 | 1,450,000 |
| 2011-09-01 | 3.5 | 7 | 2 | 2,850,000 | 1,200,000 |
| 2011-06-01 | 0.8 | 4 | 5 | 1,013,783 | 689,868 |
InspireMD Notable Stakeholders
An InspireMD stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as InspireMD often face trade-offs trying to please all of them. InspireMD's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting InspireMD's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Marvin Slosman | CEO President | Profile | |
| Sol Barer | Independent Chairman of the Board | Profile | |
| Craig Shore | CFO, Chief Admin. Officer, Secretary and Treasurer | Profile | |
| Shane Gleason | Chief Officer | Profile | |
| Roei Samuri | VP Operations | Profile | |
| DVM MD | Executive Affairs | Profile | |
| Andrea Tommasoli | Chief Officer | Profile | |
| Amir Kohen | Vice Resources | Profile | |
| Pete Ligotti | Executive America | Profile |
About InspireMD Management Performance
The success or failure of an entity such as InspireMD often depends on how effective the management is. InspireMD management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of InspireMD management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the InspireMD management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.42) | (0.44) | |
| Return On Capital Employed | (0.51) | (0.53) | |
| Return On Assets | (0.42) | (0.44) | |
| Return On Equity | (0.50) | (0.48) |
InspireMD Workforce Analysis
Traditionally, organizations such as InspireMD use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare InspireMD within its industry.InspireMD Manpower Efficiency
Return on InspireMD Manpower
| Revenue Per Employee | 95.5K | |
| Revenue Per Executive | 689.4K | |
| Net Loss Per Employee | 306.4K | |
| Net Loss Per Executive | 2.2M | |
| Working Capital Per Employee | 586.8K | |
| Working Capital Per Executive | 4.2M |
Additional Tools for InspireMD Stock Analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.